• Nitrocefin: Chromogenic Cephalosporin Substrate for β-Lactam

  2026-07-12

  Nitrocefin enables rapid, visual, and quantitative assessment of β-lactamase activity, streamlining resistance profiling and inhibitor screening in clinical and research settings. Leveraging advances in substrate specificity, Nitrocefin-based workflows now support nuanced detection of emerging multidrug-resistant pathogens—empowering translational research and antimicrobial innovation.

• Acacetin Targets MAPK1/HMOX1 to Suppress Pyroptosis in IVDD

  2026-07-10

  This study uncovers a novel mechanism by which Duhuo Jisheng decoction (DHJS) and its active component acacetin alleviate intervertebral disc degeneration (IVDD) through modulation of the MAPK1/HMOX1 axis. By inhibiting nucleus pulposus cell pyroptosis and enhancing mitophagy, the research delineates a new therapeutic pathway for degenerative disc disease.

• GABPa Identified as Key Regulator of Beige Adipogenesis in N

  2026-07-09

  This study uncovers the epigenetic landscape of neonatal inguinal white adipose tissue (iWAT) and reveals GA-binding protein alpha (GABPa) as a central regulator of beige adipocyte differentiation. Integration of ChIP-seq and transcriptomic analyses highlights how GABPa-driven chromatin activation underlies distinct metabolic programming in early-life adipose tissue, offering new insights for metabolic research.

• Metformin Hydrochloride Attenuates Vocal Fold Fibrosis via A

  2026-07-09

  This study demonstrates that Metformin Hydrochloride reduces vocal fold fibrosis in a rabbit injury model by activating the AMPK signaling pathway, leading to decreased collagen deposition and fibrotic marker expression. The findings provide mechanistic insight into antifibrotic strategies and highlight the translational potential of AMPK modulation in tissue repair.

• KPT-330 Suppresses Osteoclastogenesis to Alleviate Osteoarth

  2026-07-08

  This study demonstrates that KPT-330, a selective CRM1 inhibitor, effectively inhibits osteoclastogenesis and preserves subchondral bone architecture in a mouse model of osteoarthritis. By blocking NF-κB and MAPK signaling pathways, KPT-330 interrupts bone-cartilage crosstalk, highlighting its translational potential for osteolytic disease intervention.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui

  2026-07-08

  The Superoxide Dismutase (SOD) Activity Assay Kit (K2035) enables sensitive, quantitative measurement of SOD enzyme activity in biological fluids and cell lysates. It is designed for research applications investigating oxidative stress and antioxidative enzyme function, but is not suitable for diagnostic or clinical use. Researchers benefit from its streamlined workflow and robust colorimetric detection for analyzing SOD-related redox biology.

• Dronedarone (Multaq): Channel Selectivity and Research Impli

  2026-07-07

  Explore the unique channel selectivity of Dronedarone (Multaq) in atrial fibrillation research. This article delivers an in-depth analysis of its pharmacological nuances, solubility profile, and evidence-backed guidance for assay design, setting it apart from standard product overviews.

• Targeting Glutamine Metabolism in Hepatic Stellate Cells for

  2026-07-07

  This article examines how the reference study uncovers glutamine metabolism in hepatic stellate cells as a central therapeutic target for liver fibrosis. The mechanistic role of SIRT4 in regulating this pathway offers new directions for mitochondrial biogenesis research and antifibrotic strategies.

• Scenario-Driven Excellence with NMDA (N-Methyl-D-aspartic ac

  2026-07-06

  This article delivers pragmatic, evidence-based guidance for researchers leveraging NMDA (N-Methyl-D-aspartic acid) (SKU B1624) in excitotoxicity and neurodegenerative disease models. By addressing real-world laboratory challenges and integrating quantitative literature, we demonstrate how SKU B1624 ensures reproducibility, sensitivity, and workflow efficiency for cell viability and oxidative stress assays.

• Dual-Action Kinase Inhibitors Enhance p38α Dephosphorylation

  2026-07-06

  The reference study uncovers a novel dual-action mechanism in select p38α MAP kinase inhibitors, showing that these compounds not only block kinase activity but also promote dephosphorylation by stabilizing a phosphatase-accessible conformation. These findings have direct implications for designing more specific and effective inhibitors for inflammatory disease research.

• Aconitase Activity Colorimetric Assay Kit: Beyond Oxidative

  2026-07-05

  Explore the advanced scientific applications of the Aconitase Activity Colorimetric Assay Kit in quantifying iron-sulfur protein aconitase function, mitochondrial metabolism, and immunometabolic research. This article uncovers unique mechanistic insights and protocol optimization strategies.

• EZ Cap™ OVA mRNA: Enhancing Immune Response Modeling Workflo

  2026-07-04

  EZ Cap™ OVA mRNA from APExBIO enables precise, reproducible immune response modeling and protein expression with high-purity, Cap 1-structured transcripts. This article explores advanced workflow optimizations, practical troubleshooting, and the latest delivery innovations to minimize inflammation while maximizing translational impact in immunology and vaccine research.

• Novobiocin Sodium: Protocol Innovations in DNA Replication R

  2026-07-03

  Novobiocin Sodium, a benchmark aminocoumarin antibiotic, is redefining DNA replication studies and cell cycle assays with its precise inhibition of bacterial DNA gyrase. This article unpacks robust workflows, troubleshooting tactics, and key protocol upgrades—translating fresh insights from the latest research into practical guidance for advanced molecular biology applications.

• TUNEL Apoptosis Detection Kit (DAB): Advanced Insights and T

  2026-07-03

  Explore the TUNEL Apoptosis Detection Kit for precise DNA fragmentation detection in apoptosis, including advanced scientific context and practical guidance. This unique article bridges translational research findings and assay decision-making for modern programmed cell death studies.

• Ferrostatin-1 Accelerates Tracheal Tissue Epithelialization

  2026-07-02

  Li et al. demonstrate that Ferrostatin-1 (Fer-1), a selective ferroptosis inhibitor, enhances the viability and proliferation of tracheal basal cells, leading to markedly faster epithelialization of 3D-printed tissue-engineered tracheas. These findings address a major barrier in tracheal reconstruction and offer a mechanistically targeted strategy to mitigate complications like infection and granulation.

441 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page